Asthma: Chronopharmacotherapy and the molecular clock

Naoto Burioka, Yasushi Fukuoka, Satoru Koyanagi, Masanori Miyata, Miyako Takata, Hiroki Chikumi, Hiroshi Takane, Masanari Watanabe, Masahiro Endo, Takanori Sako, Hisashi Suyama, Shigehiro Ohdo, Eiji Shimizu

研究成果: Contribution to journalReview article査読

42 被引用数 (Scopus)


Bronchial asthma is characterized by chronic airways inflammation and reversible airflow limitation. In patients with asthma, symptoms generally worsen during the early hours of the morning, and pulmonary function often deteriorates at the same time, suggesting a role for chronopharmacotherapy. Several drugs for asthma have been developed based on chronopharmacology. Most medications employed for the chronotherapy of asthma are administered once at night with the goal of preventing chronic airway inflammation or development of airflow limitation. In addition to bronchodilators, the inhaled glucocorticosteroid ciclesonide is now available with once-daily dosing, which also improves patients' compliance. Numerous investigations have demonstrated the usefulness of chronotherapy for asthma, especially for patients with nocturnal asthma. This review focuses on chronotherapy of asthma, and also provides a molecular biological explanation for the influence of asthma medications on the clock genes.

ジャーナルAdvanced Drug Delivery Reviews
出版ステータス出版済み - 7 2010

All Science Journal Classification (ASJC) codes

  • 薬科学


「Asthma: Chronopharmacotherapy and the molecular clock」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。